EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Urinary Post-Translationally Modified Fetuin-A Protein Is Associated with Increased Risk of Graft Failure in Kidney Transplant Recipients

Firas F Alkaff, Daan Kremer, Charlotte A Te Velde-Keyzer, Jacob van den Born, Stefan P Berger, Gozewijn D Laverman, Lee-Ming Chuang, Tzu-Ling Tseng, Stephan J L Bakker

American Journal of Nephrology · 2024

DOI: 10.1159/000534829 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Nephrology, 2024. Verfasst von Firas F Alkaff und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Kidney Transplantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Urinary fetuin-A has been identified as a biomarker for acute kidney injury and is proposed as a biomarker for early detection of kidney function decline. We investigated whether fetuin-A could serve as a marker of graft failure in kidney transplant recipients (KTRs).

Methods

Data of KTR with a functioning graft ≥1 year that were enrolled in the TransplantLines Food and Nutrition Biobank and cohort study were used. Graft failure was defined as the need for re-transplantation or (re-)initiation of dialysis. Urinary fetuin-A was measured using an enzyme-linked immunosorbent assay kit that detected post-translationally modified fetuin-A in the urine (uPTM-FetA). In the main analyses, 24h uPTM-FetA excretion was used. In the sensitivity analyses, we excluded the outliers in 24h uPTM-FetA excretion, and we used uPTM-FetA concentration and uPTM-FetA concentration indexed for creatinine instead of 24h uPTM-FetA excretion.

Results

A total of 627 KTRs (age 53 ± 13 years, 42% females) were included at 5.3 (1.9–12.2) years after transplantation. The estimated glomerular filtration rate (eGFR) was 52 ± 20 mL/min/1.73 m2 and uPTM-FetA excretion was 34 (17–74) µg/24 h. During a median follow-up of 5.3 (4.5–6.0) years after baseline measurements, 73 (12%) KTRs developed graft failure. The association of 24h uPTM-FetA excretion with increased risk of graft failure was not constant over time, with increased risk only observed after 3 years from baseline measurements, independent of potential confounders including kidney function and 24 h urinary protein excretion (hazard ratio per doubling of 24h uPTM-FetA excretion = 1.31; 95% confidence interval = 1.06–1.61). This finding was robust in the sensitivity analyses.

Conclusions

Our findings suggest that uPTM-FetA can be used as a marker for early detection of graft failure in KTR. Further studies are needed to confirm our findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationFemaleHumansAdultMiddle AgedAgedMaleCohort Studiesalpha-2-HS-GlycoproteinBiomarkersRenal DialysisTransplant Recipients

Stichwörter der Autor:innen

BiomarkersFetuin-AGraft failureKidney transplantation

Substanzen

alpha-2-HS-GlycoproteinBiomarkers

Autor:innen und Institutionen

  • Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Division of Pharmacology and Therapy, Department of Anatomy, Histology, and Pharmacology, Faculty of Medicine Universitas Airlangga, Surabaya, Indonesia.
  • Department of Internal Medicine/Nephrology, Ziekenhuis Groep Twente, Almelo, The Netherlands.
  • Biomedical Signals and Systems (BSS), University of Twente, Enschede, The Netherlands.
  • Divsion of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • College of Medicine, National Taiwan University, Taipei, Taiwan.

Zitieren

APA

Alkaff, F. F., Kremer, D., Te Velde-Keyzer, C. A., van den Born, J., Berger, S. P., Laverman, G. D., Chuang, L. M., Tseng, T. L., & Bakker, S. J. L. (2024). Urinary Post-Translationally Modified Fetuin-A Protein Is Associated with Increased Risk of Graft Failure in Kidney Transplant Recipients. American Journal of Nephrology. https://doi.org/10.1159/000534829

Vancouver

Alkaff FF, Kremer D, Te Velde-Keyzer CA, van den Born J, Berger SP, Laverman GD, et al. Urinary Post-Translationally Modified Fetuin-A Protein Is Associated with Increased Risk of Graft Failure in Kidney Transplant Recipients. American Journal of Nephrology. 2024. doi:10.1159/000534829

BibTeX
@article{Alkaff2024,
  author = {Alkaff, Firas F and Kremer, Daan and Te Velde-Keyzer, Charlotte A and van den Born, Jacob and Berger, Stefan P and Laverman, Gozewijn D and Chuang, Lee-Ming and Tseng, Tzu-Ling and Bakker, Stephan J L},
  title = {Urinary Post-Translationally Modified Fetuin-A Protein Is Associated with Increased Risk of Graft Failure in Kidney Transplant Recipients},
  journal = {American Journal of Nephrology},
  year = {2024},
  doi = {10.1159/000534829}
}
Kostenlos starten →